Nuvectis Pharma (NVCT) Non-Current Deffered Revenue (2021)
Nuvectis Pharma has reported Non-Current Deffered Revenue over the past 1 years, most recently at $824000.0 for Q4 2021.
- Quarterly results put Non-Current Deffered Revenue at $824000.0 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $824000.0 (changed N/A YoY), and the annual figure for FY2021 was $824000.0, changed.
- Non-Current Deffered Revenue reached $824000.0 in Q4 2021 per NVCT's latest filing.
- Across five years, Non-Current Deffered Revenue topped out at $824000.0 in Q4 2021 and bottomed at $824000.0 in Q4 2021.